Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Clinical trial NCT02052388 · COMPLETED

Trial details

NCT number: NCT02052388
Sponsor: Cellceutix Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Skin Infection Bacterial Infection

Start date: 2014-02-01
Primary completion: 2014-10-01
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.